These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38942994)

  • 1. AAV gene therapy for hereditary spastic paraplegia type 50: a phase 1 trial in a single patient.
    Dowling JJ; Pirovolakis T; Devakandan K; Stosic A; Pidsadny M; Nigro E; Sahin M; Ebrahimi-Fakhari D; Messahel S; Varadarajan G; Greenberg BM; Chen X; Minassian BA; Cohn R; Bonnemann CG; Gray SJ
    Nat Med; 2024 Jul; 30(7):1882-1887. PubMed ID: 38942994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrathecal AAV9/AP4M1 gene therapy for hereditary spastic paraplegia 50 shows safety and efficacy in preclinical studies.
    Chen X; Dong T; Hu Y; De Pace R; Mattera R; Eberhardt K; Ziegler M; Pirovolakis T; Sahin M; Bonifacino JS; Ebrahimi-Fakhari D; Gray SJ
    J Clin Invest; 2023 May; 133(10):. PubMed ID: 36951961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paving a way to treat spastic paraplegia 50.
    Brent JR; Deng HX
    J Clin Invest; 2023 May; 133(10):. PubMed ID: 37183815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AAV-Mediated Gene Therapy for Glycosphingolipid Biosynthesis Deficiencies.
    Yang H; Brown RH; Wang D; Strauss KA; Gao G
    Trends Mol Med; 2021 Jun; 27(6):520-523. PubMed ID: 33714697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bilateral gene therapy in children with autosomal recessive deafness 9: single-arm trial results.
    Wang H; Chen Y; Lv J; Cheng X; Cao Q; Wang D; Zhang L; Zhu B; Shen M; Xu C; Xun M; Wang Z; Tang H; Hu S; Cui C; Jiang L; Yin Y; Guo L; Zhou Y; Han L; Gao Z; Zhang J; Yu S; Gao K; Wang J; Chen B; Wang W; Chen ZY; Li H; Shu Y
    Nat Med; 2024 Jul; 30(7):1898-1904. PubMed ID: 38839897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining the clinical, molecular and imaging spectrum of adaptor protein complex 4-associated hereditary spastic paraplegia.
    Ebrahimi-Fakhari D; Teinert J; Behne R; Wimmer M; D'Amore A; Eberhardt K; Brechmann B; Ziegler M; Jensen DM; Nagabhyrava P; Geisel G; Carmody E; Shamshad U; Dies KA; Yuskaitis CJ; Salussolia CL; Ebrahimi-Fakhari D; Pearson TS; Saffari A; Ziegler A; Kölker S; Volkmann J; Wiesener A; Bearden DR; Lakhani S; Segal D; Udwadia-Hegde A; Martinuzzi A; Hirst J; Perlman S; Takiyama Y; Xiromerisiou G; Vill K; Walker WO; Shukla A; Dubey Gupta R; Dahl N; Aksoy A; Verhelst H; Delgado MR; Kremlikova Pourova R; Sadek AA; Elkhateeb NM; Blumkin L; Brea-Fernández AJ; Dacruz-Álvarez D; Smol T; Ghoumid J; Miguel D; Heine C; Schlump JU; Langen H; Baets J; Bulk S; Darvish H; Bakhtiari S; Kruer MC; Lim-Melia E; Aydinli N; Alanay Y; El-Rashidy O; Nampoothiri S; Patel C; Beetz C; Bauer P; Yoon G; Guillot M; Miller SP; Bourinaris T; Houlden H; Robelin L; Anheim M; Alamri AS; Mahmoud AAH; Inaloo S; Habibzadeh P; Faghihi MA; Jansen AC; Brock S; Roubertie A; Darras BT; Agrawal PB; Santorelli FM; Gleeson J; Zaki MS; Sheikh SI; Bennett JT; Sahin M
    Brain; 2020 Oct; 143(10):2929-2944. PubMed ID: 32979048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation and characterization of six human induced pluripotent stem cell lines (iPSC) from three families with AP4M1-associated hereditary spastic paraplegia (SPG50).
    Eberhardt K; Jumo H; D'Amore A; Alecu JE; Ziegler M; Afshar Saber W; Sahin M; Ebrahimi-Fakhari D
    Stem Cell Res; 2021 May; 53():102335. PubMed ID: 34087981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Putative founder effect of Arg338* AP4M1 (SPG50) variant causing severe intellectual disability, epilepsy and spastic paraplegia: Report of three families.
    Becker A; Felici C; Lambert L; de Saint Martin A; Abi-Warde MT; Schaefer E; Zix C; Zamani M; Sadeghian S; Zeighami J; Seifi T; Azizimalamiri R; Shariati G; Galehdari H; Selig M; Ding C; Duerinckx S; Pirson I; Abramowicz M; Clément G; Leheup B; Jonveaux P; Lefort G; Bronner M; Renaud M; Bonnet C
    Clin Genet; 2023 Mar; 103(3):346-351. PubMed ID: 36371792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hereditary spastic paraplegia: from diagnosis to emerging therapeutic approaches.
    Shribman S; Reid E; Crosby AH; Houlden H; Warner TT
    Lancet Neurol; 2019 Dec; 18(12):1136-1146. PubMed ID: 31377012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progranulin AAV gene therapy for frontotemporal dementia: translational studies and phase 1/2 trial interim results.
    Sevigny J; Uspenskaya O; Heckman LD; Wong LC; Hatch DA; Tewari A; Vandenberghe R; Irwin DJ; Saracino D; Le Ber I; Ahmed R; Rohrer JD; Boxer AL; Boland S; Sheehan P; Brandes A; Burstein SR; Shykind BM; Kamalakaran S; Daniels CW; David Litwack E; Mahoney E; Velaga J; McNamara I; Sondergaard P; Sajjad SA; Kobayashi YM; Abeliovich A; Hefti F
    Nat Med; 2024 May; 30(5):1406-1415. PubMed ID: 38745011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene Therapy for Leber Hereditary Optic Neuropathy: Initial Results.
    Feuer WJ; Schiffman JC; Davis JL; Porciatti V; Gonzalez P; Koilkonda RD; Yuan H; Lalwani A; Lam BL; Guy J
    Ophthalmology; 2016 Mar; 123(3):558-70. PubMed ID: 26606867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Locus and allelic heterogeneity in five families with hereditary spastic paraplegia.
    Hebbar M; Shukla A; Nampoothiri S; Bielas S; Girisha KM
    J Hum Genet; 2019 Jan; 64(1):17-21. PubMed ID: 30337681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study.
    Ferrua F; Cicalese MP; Galimberti S; Giannelli S; Dionisio F; Barzaghi F; Migliavacca M; Bernardo ME; Calbi V; Assanelli AA; Facchini M; Fossati C; Albertazzi E; Scaramuzza S; Brigida I; Scala S; Basso-Ricci L; Pajno R; Casiraghi M; Canarutto D; Salerio FA; Albert MH; Bartoli A; Wolf HM; Fiori R; Silvani P; Gattillo S; Villa A; Biasco L; Dott C; Culme-Seymour EJ; van Rossem K; Atkinson G; Valsecchi MG; Roncarolo MG; Ciceri F; Naldini L; Aiuti A
    Lancet Haematol; 2019 May; 6(5):e239-e253. PubMed ID: 30981783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation and characterization of six human induced pluripotent stem cell lines (iPSC) from three families with AP4B1-associated hereditary spastic paraplegia (SPG47).
    Teinert J; Behne R; D'Amore A; Wimmer M; Dwyer S; Chen T; Buttermore ED; Chen IP; Sahin M; Ebrahimi-Fakhari D
    Stem Cell Res; 2019 Oct; 40():101575. PubMed ID: 31525725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hereditary spastic paraplegia: report of two siblings.
    Yeh YC; Mak SC; Chi CS
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1998; 39(2):112-5. PubMed ID: 9599901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic and phenotypic characterization of complex hereditary spastic paraplegia.
    Kara E; Tucci A; Manzoni C; Lynch DS; Elpidorou M; Bettencourt C; Chelban V; Manole A; Hamed SA; Haridy NA; Federoff M; Preza E; Hughes D; Pittman A; Jaunmuktane Z; Brandner S; Xiromerisiou G; Wiethoff S; Schottlaender L; Proukakis C; Morris H; Warner T; Bhatia KP; Korlipara LV; Singleton AB; Hardy J; Wood NW; Lewis PA; Houlden H
    Brain; 2016 Jul; 139(Pt 7):1904-18. PubMed ID: 27217339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized Trial of Botulinum Toxin Type A in Hereditary Spastic Paraplegia - The SPASTOX Trial.
    Diniz de Lima F; Faber I; Servelhere KR; Bittar MFR; Martinez ARM; Piovesana LG; Martins MP; Martins CR; Benaglia T; de Sá Carvalho B; Nucci A; França MC
    Mov Disord; 2021 Jul; 36(7):1654-1663. PubMed ID: 33595142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel SPAST gene mutation identified in a Chinese family with hereditary spastic paraplegia.
    Yu W; Jin H; Deng J; Nan D; Huang Y
    BMC Med Genet; 2020 Jun; 21(1):123. PubMed ID: 32493220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adeno-associated virus vectors for gene therapy: more pros than cons?
    Monahan PE; Samulski RJ
    Mol Med Today; 2000 Nov; 6(11):433-40. PubMed ID: 11074369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. X linked spastic paraplegia (SPG2): clinical heterogeneity at a single gene locus.
    Bonneau D; Rozet JM; Bulteau C; Berthier M; Mettey R; Gil R; Munnich A; Le Merrer M
    J Med Genet; 1993 May; 30(5):381-4. PubMed ID: 8320699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.